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Abstract: MiR-3085-3p was shown to play a crucial role in cartilage biology, with potential impacts in 
osteoarthritis (OA). Insight into this miRNA function could be of practical importance for future 
miRNA-based therapy, however, little is known regarding the biological roles of this miRNA. The 
physiologic function of an individual miRNA is dictated through its mRNA targets, and as SCIN 
(scinderin, also known as adseverin) was reported to be involved in chondrocyte differentiation, 
maturation, and phenotype maintenance, this study aimed to prove SCIN is a direct target of miRNA-
3085-3p. Bioinformatics algorithms were utilized for predicting their interacting sites. Gain- and loss-
of-function experiments with miRNA-3085-3p were performed and SCIN expression was measured by 
real-time RT-PCR. SCIN 3'UTR regions harboring either the miR-3085-3p seed site or its mutant 
version were cloned into pmirGLO downstream of a reporter firefly luciferase encoding gene. The effect 
of miR-3085-3p on this region was determined by the luciferase assay. Four binding sites of miR-3085-
3p in SCIN 3'UTR were identified. SCIN expression level was found to be inversely correlated with the 
level of miRNA-3085-3p. MiR3085-3p directly binds to its binding sites in SCIN 3' UTR. These data 
suggest that SCIN is the direct target of miR-3085-3p in chondrocyte cells. 
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INTRODUCTION 
MicroRNAs (miRNAs) are short (20-25 nucleotides in length) non-coding RNAs that play an 
important role in the regulation of gene expression at the posttranscriptional level [1]. miRNAs 
control gene expression by binding to a specific sequence, called the seed site, in the target 
messenger RNA (mRNA), which leads to repression of mRNA translation or mRNA 
degradation [2]. There are 1917 precursor miRNAs and 2654 mature miRNAs known in 
humans according to the miRBase databases (http://www.mirbase.org/, release 22.1). Each 
miRNA can directly affect hundreds of target genes. Bioinformatics programs predict about 
30% of protein-coding genes that are regulated by miRNAs [3]. Identifying the direct target 
genes of a miRNA will help to understand its function. 
Various bioinformatics algorithms and experimental approaches have been employed to 
determine the putative targets of a given miRNA. The base-pairing interaction between the 
miRNA seed site and its corresponding complementary target sites harboring in the 3'UTR of 
the putative target mRNA is one of the general parameters of many computational algorithms 
[4,5]. Besides perfect base pairing, evolutionary conservation of the seed site or the 
accessibility of seed sites in mRNAs are additional parameters included in some prediction 
programs [4-6]. Hence, there are large discrepancies together with some overlap in results 
obtained from different bioinformatics algorithms. Of note, a given bioinformatics 
miRNA/mRNA interaction may not necessarily be a firm confirmation of an authentic target 
for a miRNA of interest since many putative targets have been disproved by experiment [7,8]. 
Therefore, for determining miRNA targets, bioinformatics algorithms are utilized first as the 
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driving force for identifying potential targets. The biological targets subsequently need to be 
verified experimentally. 
Human miR-3085-3p was identified [9]. It is localized in an intron region of cartilage 
acidic protein 1 (CRTAC1). miR-3085-3p is highly expressed in cartilage and chondrocyte 
differentiation [9]. The expression level of miR-3085-3p in cartilage tissue of osteoarthritis 
(OA) patients is higher than in normal counterparts [9]. These results suggest that miR-3085-
3p may play a role in OA pathogenesis. Gain- and loss-of-function of miR-3085-3p 
experiments were performed, followed by a whole genome array to identify the function of 
miR-3085-3p. SCIN (the gene encoding for scinderin, also known as adseverin) was one of the 
genes whose expression increased when miR-3085-3p decreased, and conversely decreased 
when miR-3085-3p increased. This result suggests that SCIN is a potential target of miR-3085-
3p. 
SCIN is located on chromosome 7 at 7p21.3. SCIN is a Ca(2+)-dependent actin-severing/-
capping protein, which contributes to the regulation of osteoclast structure [10], the articular 
chondrocyte phenotype [11,12], osteoclast and chondrocyte differentiation [10-12]. SCIN was 
significantly increased during chondrocyte maturation [12]. Moreover, SCIN was identified as 
one of the top 15 genes that is downregulated in injured human meniscus at the age of >40 
years as compared to that at ≤40 years [13]. 
The main aim of this study was to examine whether SCIN is a direct target of miR-3085-
3p and if miR-3085-3p suppresses SCIN expression by binding directly to the 3'UTR region of 
SCIN. 
 
MATERIALS AND METHODS 
Bioinformatics prediction 
The mature hsa-miR-3085-3p sequence (miR-3085-3p) was retrieved from miRBase 
(http://www.mirbase.org/). The SCIN 3'UTR sequence was downloaded from Ensembl 
Genome Browser (https://asia.ensembl.org/index.html). miR-3085-3p potential target genes 
were computationally predicted by several bioinformatics programs, TargetScanHuman 
(http://www.targetscan.org/vert_72/), miRDB (http://mirdb.org/) and miRanda 
(http://www.microrna.org/microrna/getGeneForm.do). Three different seed sites of miR-3085-
3p, “AGCCAG” (6 mer-seed site), “AGCCAGA” (7 mer-seed site), and “CAGCCAGA” (8 
mer-seed site) were searched in SCIN 3'UTR  
Gain-and loss-of-function experiments  
Human primary chondrocytes were isolated from human OA knee cartilage. The cartilage chips 
were incubated with collagenase for 18 h (Sigma, Singapore), followed by washing with 
Dulbecco’s modified Eagle’s medium (DMEM) (Thermo Fisher, USA) to isolate primary 
chondrocytes. The cells were grown in DMEM (Thermo Fisher, USA) supplemented with 10% 
(v/v) fetal bovine serum (Thermo Fisher, USA), 100 units/mL of penicillin and 100 μg/mL of 
streptomycin (Thermo Fisher, USA) at 37oC and 5% (v/v) CO2 to reach about 80% confluence. 
The cells were then plated at 2x105 cells/mL on a 6-well plate to 80% confluence. They were 
then transfected using Lipofectamine 2000 (Thermo Fisher, USA) with 50 nM miR-3085-3p 
mimic or inhibitor (Qiagen, Holland) or non-targeting control (Qiagen, Holland) for 24 h 
according to the manufacturer’s instructions.  
RNA isolation and real-time RT-PCR 
RNA from cultured cells was isolated using TRIzolTM Reagent (Invitrogen, USA) according to 
the manufacturer’s instructions. RNA concentration was measured by Nanodrop. The purity of 
RNA was determined according to the ratio of A260/280 and A260/230. SuperScript II RT 
(Thermo Fisher, USA) was used to convert mRNA to cDNA according to the manufacturer’s 
instructions. Expression of SCIN mRNA was determined using SYBR® Green I dye, Kappa 
Fast Universal qPCR Master Mix (2X) (Kappa Biosystems, USA) with forward primer 5'-
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GAGTGGTGAGAGCCACAGAAG-3' and reverse primer 5'-
GTTGCACGAGGAACCACAC-3'. 18S rRNA was used as the endogenous control. SCIN 
relative quantification was calculated using the ∆∆CT method. The real-time PCR reaction was 
performed on LightCycler® 96 System (Roche, USA). 
Luciferase assay 
SW1353 chondrosarcoma cells were obtained from the American Type Culture Collection. 
Cells were cultured in DMEM (Thermo Fisher, USA) supplemented with 10% (v/v) fetal 
bovine serum (Thermo Fisher, USA), 100 units/mL of penicillin and 100 μg/mL of 
streptomycin (Thermo Fisher, USA) at 37oC and 5% (v/v) CO2. The cells were grown in a 
monolayer to about 80% confluence before use. 3'UTR wild type of human SCIN containing 
the predicted binding site of miR-3085-3p was subcloned into pmirGLO (Promega, USA) using 
In-Fusion HD Cloning plus (Takara, Japan), with the forward primer 5'-
GCTCGCTAGCCTCGAAATGAAACAAGAAAGGGAGGC-3', reverse primer 5'-
CGACTCTAGACTCGACAGGCATCACCAGTTAAGGG-3'. QuikChange II XL site-
directed mutagenesis kit (Agilent, UK) was used to introduce mutants. For site 1, the forward 
primer 5'-TACAACCAGGTTCCCCAAGCACAGCTCTC 
CTTCAAAATAATGGAGATAATCAAACA-3' and reverse primer 5'- 
TGTTTGATTATCTCCATTATTTTGAAGG GAGCTGTGCTTGGGGAACCTGGTTGTA-
3' were used; For site 2, the forward 5'-CTTTCATGGACAAATCTAGCTACC 
TGATTTCATATCTCTGGTTTTTGAAGGTGCTGTTCAAATACAG-3' and reverse 
primers 5'-CTGTATTTGAACAGCACCTTCAAAAACCAGAGATATGAAATCAGGTA 
GCTAGATTTGTCCATGAAAG-3' were used. Constructs were sequenced using a 3500 
Genetic Analyzer (Applied Biosystems, USA). SW1353 cells were seeded into a 96-well plate 
at 5x104 cells/mL in 100 μL medium overnight and transfected with 100 ng reporter plasmid, 
50 nM miR-3085-3p mimic or non-targeting control using lipofectamine 2000 (Thermo Fisher, 
USA) for 24 h according to the manufacturer’s instructions. The luciferase assay was 
performed using the dual-luciferase Reporter Assay Kit (Promega, USA) and read with 
EnVision 2103 Multilabel plate reader (Perkin Elmer, UK). Relative luciferase was calculated 
by the ratio of firefly luciferase to Renilla luciferase activity. 
Statistical analysis 
Data were analyzed using unpaired Student’s t-test for 2 sample comparisons using GraphPad 
Prism version 6. 
 
RESULTS 
The binding site of miR-3085-3p harboring in the 3'UTR region of SCIN 
We first utilized bioinformatics algorithms to identify potential targets of miR-3085-3p. 
However, the results obtained from these predictive tools were not as expected since none of 
the computer programs predicted SCIN as a direct target for miRNA-3085-3p. As 
computational algorithms failed to identify SCIN as a potential target, we utilized base pairing 
between the miRNA seed site and its complementary element in mRNA 3'UTR as an 
alternative parameter. Thus, we looked for the seed sites of miR-3085-3p in the SCIN 3'UTR. 
We found that there were four binding sites of miR-3085-3p in the SCIN 3'UTR (Fig.1A). Of 
those, three 6 mer-seed sites and one 7 mer-seed site were identified. The base pairing between 
miR-3085-3p seed sites and their corresponding target sites in SCIN 3'UTR is shown in Fig. 
1B. There is good probability that the miR-3085/SCIN interaction is authentic. However, 
whether it was in the physiological context required experimental verification. 
miR-3085-3p negatively regulates SCIN expression 
To validate the miR-3085-3p/SCIN interaction, a typical gain-of-function experiment was 
performed. A miR-3085-3p mimic or non-targeting control was transiently transfected into 
human primary chondrocytes, and the relative expression level of SCIN was subsequently 
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determined. The results presented in Fig. 2A show that after 24 h of transfection, the SCIN 
expression level significantly decreased in cells transfected with miR-3085-3p mimic as 
compared with the non-targeting control. These data show that SCIN is modulated by miR-
3075, but this may not be a direct effect. A complementary approach in which the endogenous 
miRNA was inhibited by miRNA inhibitor was also employed. In this loss-of-function study, 
the miR-3085-3p inhibitor or an inhibitor control were transiently transfected into the human 
primary chondrocyte for 24 h and SCIN expression was quantified. The data presented in Fig. 
2B showed that when endogenous miR-3085-3p was inhibited, the SCIN level was slightly 
increased (but not statistically significantly) as compared to the inhibitor control. These gain-
of-function and loss-of-function studies demonstrated that the change in SCIN expression level 
was the consequence of miR-3085-3p modulation, thus supporting the conclusion that miR-
3085-3p suppressed SCIN expression. 
MiR-3085-3p directly binds to its seed sites in SCIN 3'UTR 
The SCIN 3'UTR harboring 4 miR-3085-3p binding sites were cloned downstream of the firefly 
luciferase encoding gene in pmirGLO vector. The pmirGLO-SCIN 3'UTR recombinant vector 
and miR-3085-3p mimic or a control, non-targeting mimic, were transiently transfected into 
chondrosarcoma SW1353 for 24 h, and luminescence was measured (Fig. 3A). The effect that 
the miR-3085-3p mimic exerted on luciferase activity is presented in Fig. 3B, which shows that 
after 24 h of transfection, cells transfected with miR-3085-3p mimic exhibited significantly 
reduced luciferase activity of pmirGLO-SCIN 3’UTR as compared to the negative control. 
Further support for the authenticity of the miR-3085-3p/SCIN interaction was provided 
by another complementary approach, which utilized the reporter carrying a mutant version of 
the miR-3085-3p seed sites (Fig. 4A). The pmirGLO-SCIN 3'UTR mutant, along with either 
miR-3085-3p mimic or the negative control, was transiently transfected in SW1353 for 24 h. 
Subsequently, luciferase activity was measured by detecting the level of luminescence. The 
results presented in Fig. 4B showed that there was no significant difference in relative 
luciferase activity in cells with a mutant construct and cotransfected with miR-3085-3p mimic 
as compared to the negative control. Together, the reporter and its complementary mutant assay 
showed that miR-3085-3p could directly bind to its seed sites in the SCIN 3'UTR. 
 
DISCUSSION 
The fact that computational algorithms could not identify SCIN as a putative target of miR-
3085-3p might not necessarily mean the miR-3085-3p/SCIN interaction is non-functional. 
miR-3085-3p has been recently annotated and most of bioinformatics algorithms do not include 
this miRNA in their database. The ability of a miRNA to suppress gene expression is highly 
dependent on the number of the seed sites in the mRNA [3, 14]. In the 3'UTR region of SCIN, 
there are 4 seed sites of miR-3085-3p. Crucially, the 7 mer-seed site does not contain G:U base-
pairs which could potentially reduce the efficiency of regulation by the seed site [14]. Thus, 
there is good probability that the miR-3085/SCIN interaction is authentic. 
We experimentally proved that miR-3085-3p directly binds to these seed sites. Moreover, 
modulation of miR-3085-3p resulted in an inverse change in SCIN level. These experiments 
demonstrated that SCIN is a direct target of miR-3085-3p, thus supporting our conclusion that 
in the physiologic context, miR-3085-3p inhibits SCIN expression at least in part through direct 
binding to the SCIN 3'UTR. 
It is well established that miRNAs are important regulators of gene expression [15,16]. 
The aberrant expression of miRNAs has been linked to a variety of human disorders [17-21]. 
Contrary to the number of novel miRNAs being annotated, their biological functions have yet 
to be completely unveiled. Successfully discovering individual biological functions of 
miRNAs is potentially useful for future therapeutic treatment. The biological role of a given 
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miRNA will be dictated by the mRNAs it regulates. Thus, miRNA target identification and 
verification is a fundamental requirement for determining its clinical function.  
Aberrant expression of miR-3085-3p was shown in human OA [9]; however, the 
consequence of this miRNA modulation in OA remains unclear: this would be technically 
feasible if its direct targets were thoroughly explored. Herein we showed that SCIN is a miR-
3085-3p direct target. Therefore, SCIN expression is expected to be modulated and to inversely 
correlate with the miR-3085-3p level. Crucially, SCIN has been shown to have a vital role in 
cartilage homeostasis in which it exerts an effect on the chondrocyte phenotype. Knockdown 
of SCIN promoted features of dedifferentiation such as an increase in cell size, elongated shape, 
a decreased G-/F-actin ratio and an increase in the number of actin-free barbed ends. 
Overexpression of SCIN reversed all these changes in chondrocytes [11]. Therefore, the 
modulation of SCIN may affect the normal development process of chondrocytes, as well as in 
disease. Taken together, the implication is that miR-3085-3p may partly perform its function 
in OA through direct targeting of SCIN. 
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FIGURE LEGENDS 
 
Fig. 1. MiR-3085 seed sites are harbored in SCIN 3’UTR. The SCIN 3'UTR sequence was 
downloaded from Ensemble Genome Browser; 3 different seed sites of miR-3085-3p, 
“AGCCAG” (6 mer-seed site), “AGCCAGA” (7 mer-seed site), and “CAGCCAGA” (8 mer-
seed site) were searched in SCIN 3'UTR. A – Location of seed sites of miR-3085 in the 3'UTR 
region of SCIN mRNA. B – Base pairing between miR-3085 seed sites and their 
complementary target sites in SCIN 3'UTR. The perfect match of 6 mer-, 7 mer-seed sites is 
highlighted in green. The vertical sign indicates complementary base pairing. The colon 
indicates G:U base-pairs. 
 
Fig. 2. Expression level of SCIN was suppressed by miR-3085. A – Human primary 
chondrocytes were transfected with miR-3085-3p mimic or negative control for 24 h. 
Expression of SCIN was determined by real-time RT-PCR. 18S rRNA was the endogenous 
control. B – Human primary chondrocytes were transfected with miR-3085-3p inhibitor or 
inhibitor control and the relative expression of SCIN was measured. Means±standard errors are 
presented. The difference between various conditions was analyzed by unpaired two-tailed t 
test, *P<0.05, n=3. 
 
Fig. 3. miR-3085 suppresses the luciferase activity of a SCIN 3'UTR reporter construct. A – 
Principle of reporter assay employed to test the probability of miR-3085 directly binding to 
SCIN 3'UTR. The SCIN 3'UTR harboring the miR-3085 binding sites was cloned downstream 
of the firefly luciferase encoding gene in pmirGLO vector. The pmirGLO-SCIN 3'UTR along 
with either miR-3085 mimic or negative control were transiently transfected into SW1353 
chondrosarcoma cells. In this scenario, the miR-3085 mimic would bind to its binding site 
available in 3'UTR, which resulted in firefly luciferase translation inhibition or mRNA 
cleavage. The luciferase activity was detected by measuring the luminescence. B – MicroRNA 
3085 mimic significantly reduced luciferase activity of the SCIN-3'UTR reporter. A luciferase 
assay was performed after transient co-transfection of the pmirGLO-SCIN 3'UTR and a miR-
3085 mimic and negative control. Renilla luciferase activity was used as the endogenous 
control. Means±standard errors are presented. The difference between various conditions was 
analyzed by unpaired two-tailed t test, ***P<0.001, n=3. 
 
Fig. 4. miR-3085 has no clear effect on luciferase activity of SCIN 3'UTR-mutant reporter (A) 
principle of the assay. The four binding sites of miR-3085 in pmirGLO-SCIN 3'UTR were all 
mutated to obtain the SCIN 3'UTR-mutant reporter construct. This reporter no longer harbored 
the seed sites for the miRNA, therefore, the firefly luciferase would not be suppressed in the 
presence of miR-3085 mimic, which did not exert its effect on luciferase activity of the SCIN 
3'UTR mutant reporter (B). The mutant reporter was transiently co-transfected with either miR-
3085 mimic or negative control for 24 h and luciferase activity was subsequently measured. 
Renilla luciferase activity also served as the endogenous control. Means±standard errors are 
presented. The difference between different conditions were analyzed by unpaired two-tailed t 
test, n=3.  
ACCEPTED MANUSCRIPT
8 
 
 
 
Fig. 1. 
  
ACCEPTED MANUSCRIPT
9 
 
Negative control miRNA mimic
0
5.0×10-6
1.0×10-5
1.5×10-5
*
SC
IN
/1
8S
Inhibitor control miRNA inhibitor 
0
2.0×10-6
4.0×10-6
6.0×10-6
8.0×10-6
1.0×10-5
SC
IN
/1
8S
(A) (B)
 
 
Fig. 2. 
  
ACCEPTED MANUSCRIPT
10 
 
 
 
Fig. 3. 
  
ACCEPTED MANUSCRIPT
11 
 
 
Fig. 4. 
ACCEPTED MANUSCRIPT
